Pulmonary delivery of low-dose dexamethasone significantly reduces toxicity in acute lung injury therapy

Key Points

• Low-dose dexamethasone reduces toxicity in the treatment of acute lung injury, demonstrating a significant therapeutic advantage.
• A decrease in adverse effects was noted, with toxicity levels substantially lower compared to traditional therapies.
• The approach involved pulmonary delivery methods that enhance lung-targeted therapy and limit systemic exposure.
• These findings highlight the need for safer therapeutic strategies in acute lung injury management, further studies may enhance treatment protocols.